Ex Parte NEERVEN - Page 3

             Appeal 2007-1070                                                                  
             Application 09/467,901                                                            


                         1. A method of detecting and/or quantifying an IgE                    
                   antibody specific to a ligand in the form of an antigen, an                 
                   antibody, or a hapten in a liquid sample suspected to contain the           
                   IgE antibody comprising the steps of:                                       
                         (a) contacting (i) the sample with (ii) a free dissolved              
                   ligand in the form of an antigen, an antibody, or a hapten to               
                   form a mixture I comprising complexes that comprise the IgE                 
                   antibody and the ligand (IgE-containing complexes),                         
                         (b) mixing the mixture I with a carrier to which is                   
                   bound (iii) an IgE receptor, wherein said IgE receptor is CD23              
                   (FсεRII) and/or FсεRI, to form a mixture II comprising carrier-             
                   bound IgE-containing complexes,                                             
                         (c) separating the carrier-bound IgE-containing                       
                   complexes from the mixture II, and                                          
                         (d) determining the amount of the carrier-bound IgE-                  
                   containing complexes formed by detecting a label present in the             
                   carrier-bound IgE-containing complexes,                                     
                         wherein the label to be detected is associated with the               
                   ligand or the IgE antibody and wherein the label to be detected             
                   is added to the complexes present in steps (a), (b), or (c) and             
                   does not form part of the carrier.                                          
                         6. A method of detecting and/or quantifying an IgE                    
                   antibody specific to a ligand in the form of an antigen, an                 
                   antibody, or a hapten in a liquid sample suspected to contain the           
                   IgE antibody comprising the steps of:                                       
                         (a)  contacting (i) the sample with (ii) a free dissolved             
                   ligand in the form of an antigen, an antibody, or a hapten to               
                   form a mixture I comprising complexes that comprise the IgE                 
                   antibody and the ligand (IgE-containing complexes),                         



                                              3                                                

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next

Last modified: September 9, 2013